Abstract
Onychomycosis is the most common nail disease and describes the invasion of the nail by fungi. In most cases, treatment of onychomycosis requires systemic antifungals, with duration of administration ranging from 2 to several months. Cure rates range from 60% to 80%, and relapses are not rare (up to 20% of patients). New antifungals providing higher cure rates and less relapses are, therefore, auspicable. A review of onychomycoses and their treatment is made and the new antifungal drugs that are currently on study or already available are presented.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 155-159 |
| Number of pages | 5 |
| Journal | Giornale Italiano di Dermatologia e Venereologia |
| Volume | 141 |
| Issue number | 2 |
| State | Published - Apr 2006 |
| Externally published | Yes |
Keywords
- Antimicotics
- Nails
- Posaconazole
- Ravuconazole
- Voriconazole
ASJC Scopus subject areas
- Dermatology
Fingerprint Dive into the research topics of 'Emerging agents for onychomycosis'. Together they form a unique fingerprint.
Cite this
Piraccini, B. M., Iorizzo, M., Rech, G., & Tosti, A. (2006). Emerging agents for onychomycosis. Giornale Italiano di Dermatologia e Venereologia, 141(2), 155-159.